| Spirig HealthCare AG - Movymia, Injektionslösung |
| 66818 | | 01 | | Movymia | | Injektionslösung | | H05AA02 | | Teriparatide | | 17.10.2018 | | |
|
| Composition |
| teriparatidum ADNr 250 µg, acidum aceticum glaciale, natrii acetas trihydricus, mannitolum, conserv.: metacresolum 3 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Teriparatidum Adnr | 250 µg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Teriparatidum Adnr | 250 mcg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidum Aceticum Glaciale | | | | Mannitol | | | | Metacresol | 3 mg/ml | conserv. | | Sodium Acetate Trihydrate | | |
| |
|
|
